Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Dicalcium phosphate dihydrate°¡ Æ÷ÇÔµÈ mineral trioxide aggregatesÀÇ ¼¼Æ÷µ¶¼º ¹× Á¶Á÷¿°Áõ¹ÝÀÀ

Evaluation of cytotoxicity and inflammatory tissue response of mineral trioxide aggregates containing dicalcium phosphate dihydrate

´ëÇÑÄ¡°úÀç·áÇÐȸÁö 2021³â 48±Ç 2È£ p.125 ~ 134
¹ÚÇöÁ¦, ¹ÚÈñö, ¼Õ±âÅÂ, ±è¿ëÁØ, ¿ì·¹·¹, ÃÖ»óÈÆ, ¾çÇüö,
¼Ò¼Ó »ó¼¼Á¤º¸
¹ÚÇöÁ¦ ( Park Hyun-Jae ) - Seoul National University School of Dentistry Department of Dental Biomaterials Science
¹ÚÈñö ( Park Hee-Chul ) - Seoul National University School of Dentistry Department of Dental Biomaterials Science
¼Õ±âÅ ( Son Gi-Tae ) - Seoul National University School of Dentistry Department of Dental Biomaterials Science
±è¿ëÁØ ( Kim Yong-Joon ) - Seoul National University School of Dentistry Department of Dental Biomaterials Science
¿ì·¹·¹ ( Wu Le-Le ) - Seoul National University School of Dentistry Department of Dental Biomaterials Science
ÃÖ»óÈÆ ( Choi Sang-Hoon ) - Seoul National University School of Dentistry Department of Dental Biomaterials Science
¾çÇüö ( Yang Hyeong-Cheol ) - Seoul National University School of Dentistry Department of Dental Biomaterials Science

Abstract

º» ¿¬±¸¿¡¼­´Â Mineral Trioxide Aggregate(MTA)ÀÇ »ýüÀûÇÕ¼º¿¡ ´ëÇÑ dicalcium phosphate dihydrate (DCPD)ÀÇ¿µÇâÀ» Æò°¡ÇÏ°íÀÚ ÇÏ¿´´Ù. MTA °æÈ­ ½Ã ¹ß»ýÇÏ´Â pH »ó½ÂÀ» ¾ïÁ¦ÇÏ°íÀÚ DCPD¸¦ OrthoMTA¿¡ ÷°¡ÇÏ¿© ¼¼Æ÷µ¶¼º°úÇÇÇÏ¿°Áõ¹ÝÀÀÀÇ º¯È­¸¦ °üÂûÇÏ¿´´Ù. Àλê¿ÏÃæ»ý¸®½Ä¿°¼ö¿¡ ħÁöÇÑ OrthoMTA¿Í DCPD-OrthoMTAÀÇ pH¸¦ ÃøÁ¤ÇÑ°á°ú, OrthoMTA¿Í DCPD-OrthoMTA´Â ÃøÁ¤ 1ÀÏ°¿¡ °¢°¢ 12.5¿Í 12.0ÀÇ pH¸¦ º¸¿´´Ù. ¸¶Áö¸· ÃøÁ¤½ÃÁ¡ÀÎ 19ÀÏ¿¡OrthoMTA´Â Æò±Õ 11.6À» º¸ÀÎ ¹Ý¸é, DCPD-OrthoMTA´Â 8.8À» ³ªÅ¸³»¾ú´Ù. NIH 3T3 ¼¶À¯¾Æ¼¼Æ÷¿¡ ´ëÇÑ ¼¼Æ÷µ¶¼ºÀº³ôÀº ³óµµÀÇ ¿ëÃâ¾×(50% ÀÌ»ó)¿¡¼­ DCPD°¡ OrthoMTAÀÇ ¼¼Æ÷µ¶¼ºÀ» ¾ïÁ¦ÇÏ´Â È¿°ú¸¦ º¸¿´´Ù(p < 0.05). ¸¶¿ì½º ÇÇÇÏÀ̽ĽÃÇè¿¡¼­´Â ProRoot MTA, OrthoMTA, DCPD-OrthoMTA °£ÀÇ ¿°Áõ¹ÝÀÀÀÇ Â÷ÀÌ´Â ¹ß»ýÇÏÁö ¾Ê¾Ò´Ù. µû¶ó¼­ DCPDÀÇMTA ¼¼Æ÷µ¶¼ºÀ» ³·Ãß´Â È¿°ú¿Í º» ½ÇÇè Á¶°Ç¿¡¼­ÀÇ ÇÇÇÏ¿°Áõ¹ß»ý¿¡ ´ëÇÑ ¿µÇâÀº ¼­·Î À¯ÀÇÇÑ »ó°ü°ü°è¸¦ º¸ÀÌÁö¾Ê´Â °ÍÀ¸·Î »ç·áµÈ´Ù.

The purpose of this study was to evaluate the effect of dicalcium phosphate dihydrate (DCPD) on the biocompatibility of mineral trioxide aggregate (MTA). DCPD was added to MTA (OrthoMTA) to suppress the increase in pH of MTA during hardening, and the change of pH, cytotoxicity, and subcutaneous inflammation reactions in mouse model were observed. The pH of OrthoMTA and DCPD-OrthoMTA at 1st day in phosphate-buffered saline was 12.5 and 12.8, respectively. At 19th day, the pH was 11.6 (OrthoMTA) and 8.8 (DCPD-OrthoMTA). Cytotoxicity of DCPD-OrthoMTA extract was lesser than that of OrthoMTA at high concentration (above 50%) (p<0.05). No significant differences appeared in subcutaneous inflammatory reactions among ProRoot MTA, OrthoMTA and DCPD-OrthoMTA. Therefore, it is likely that there is no apparent relationship between the cytotoxicity and subcutaneous inflammation in our experimental conditions.

Å°¿öµå

Mineral trioxide aggregates; Dicalcium phosphate dihydrate; ¼¼Æ÷µ¶¼º; ÇÇÇÏ¿°Áõ
Mineral trioxide aggregates; Dicalcium phosphate dihydrate; Cytotoxicity; Subcutaneous inflammation

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KCI